Vyne Therapeutics Inc (VYNE) support and resistance · rev $501.0K
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
This page maps Vyne Therapeutics Inc (VYNE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
VYNE currently screens at market cap $21.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VYNE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VYNE quote page for the session range and the stock page for the full model.
Not investment advice.